Group 1 - The announcement refers to a collective asset management plan named "Shenwan Hongyuan Tiantianli Money Market Collective Asset Management Plan" which is subject to regulatory changes and is in the process of applying for public fund management qualifications [1] - Upon obtaining public fund management qualifications, the management will register the collective plan as a public fund in accordance with relevant regulatory requirements [1] Group 2 - The management of the collective plan commits to managing and utilizing the assets with principles of honesty, credit, and diligence, but does not guarantee profits or minimum returns [2] - Investors are advised to carefully read the asset management contract, prospectus, and product information summary before investing in the collective plan [2]

Core Viewpoint - The performance of listed securities firms in China has shown significant growth in the first half of 2025, raising questions about the sustainability of this momentum in the second half and the potential for mid-term dividend plans [1][2][4]. Group 1: Performance and Growth - Several securities firms reported strong net profit growth in the first half of 2025, driven by increases in brokerage, securities investment, and investment banking revenues [2]. - The A-share market's positive performance in the first half has contributed to the revenue growth of securities firms, leading to heightened investor interest in whether this growth can be maintained in the second half [2][3]. Group 2: Mid-term Dividend Plans - CITIC Securities announced a mid-term profit distribution plan, proposing a cash dividend of 2.90 yuan per 10 shares, totaling 4.298 billion yuan, marking an increase from the previous year's 3.557 billion yuan [4]. - Northeast Securities is also planning to implement a proactive and sustainable profit distribution policy, considering various factors such as company development and market trends [4]. Group 3: Differentiated Competitive Advantages - Smaller and specialized securities firms are exploring differentiated development paths to enhance their competitive advantages [5]. - Southwest Securities attributed its profit growth to the active A-share market and its strategic reforms aimed at building unique competitive strengths [6]. - Northeast Securities aims to establish itself as a comprehensive securities firm focused on small and innovative enterprises, enhancing its competitive edge in wealth management and investment banking [6].

证券之星消息，9月3日申万宏源证券资产管理有限公司发布《申万宏源季季优选3个月滚动持有债券型 集合资产管理计划基金暂停申购（定期定额投资）公告》。公告中提示，为本集合计划存续期将届满， 后续处置方案存在不确定性，为保护投资者利益，本集合计划暂停申购、定期定额投资，自2025年9月5 日起申万宏源季季优选3个月滚动持有债券型集合资产管理计划基金暂停申购（定期定额投资），下属 分级基金调整明细如下： | 分级基金简称 | 代码 | 是否暂停（大额）申购 (转入转出、赎回、定投) | 申购限额 转入限额 (元) (元) | 定投限额 (元) | | --- | --- | --- | --- | --- | | 申万宏源季季优选3个 | 970197 | 를 | | | | 月滚动持有债券A | | | | | | 申万宏源季季优选3个 月滚动持有债券B | 970198 | 를 | | | | 申万宏源季季优选3个 月滚动持有债券C | 970199 | 를 | | | 以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成 投资建议。 ...

Group 1 - The A-share market has experienced a pullback for two consecutive days, with the Shanghai Composite Index falling over 1% and the ChiNext Index rising by 0.95% on September 3, indicating mixed market sentiment [1][4] - The leading securities ETF (560090) has seen a decline of 3.07% but recorded a premium of 1.03% at the end of the trading day, suggesting strong buying interest despite the overall market weakness [1][4] - Over the past three days, there has been a net inflow of over 160 million yuan into the securities ETF, indicating continued investor interest in the sector [1][4] Group 2 - The majority of the index components for the leading securities ETF have experienced declines, with notable drops in stocks such as Dongfang Caifu (down over 4%) and CITIC Securities (down over 3%) [3] - The securities industry has shown resilience, with a reported revenue of 251.036 billion yuan in the first half of the year, reflecting a year-on-year growth of 23.47%, and a net profit of 112.28 billion yuan, up 40.37% [4][6] - The outlook for the second half of 2025 suggests that the securities industry may further demonstrate performance elasticity, supported by high trading volumes and normalized equity financing [6]

Group 1 - The company, Shenwan Hongyuan (000166)(06806), announced the issuance of corporate bonds aimed at professional investors for the year 2023 [1] - The bonds are referred to as "23 Shenhong 04" with the bond code 148449 [1] - The interest payment of 2.85 yuan (including tax) per bond will be made on September 5, 2025, covering the period from September 5, 2024, to September 4, 2025 [1]

Group 1 - The company, Shenwan Hongyuan (06806), announced the issuance of corporate bonds aimed at professional investors for the second phase in 2023 [1] - The bond, referred to as 23 Shenhong 04 with the code 148449, will pay interest of 2.85 yuan (including tax) per bond from September 5, 2024, to September 4, 2025 [1]

公司债券（第二期）（品种二）（债券简称：23 申宏 04，债券代码： 特别提示： 证券代码：000166 证券简称：申万宏源 公告编号：临 2025-72 债券代码：148449 债券简称：23 申宏 04 申万宏源集团股份有限公司 （品种二）2025年付息公告 本公司及全体董事会成员保证公告内容的真实、准确和完整，没 有虚假记载、误导性陈述或者重大遗漏。 月 4 日期间的利息 2.85 元（含税）/张。 月 4 日（含）前买入并持有本期债券的投资者享有本次派发的利息； 由申万宏源集团股份有限公司（以下简称"本公司"）于 2023 年 9 月 5 日发行的申万宏源集团股份有限公司 2023 年面向专业投资 者公开发行公司债券（第二期） （品种二） （以下简称"本期债券"） 至 2025 年 9 月 5 日将期满 2 年。根据本期债券《募集说明书》和《上 市公告》有关条款的规定，在本期债券的计息期限内，每年付息一次， 为确保付息工作的顺利进行，现将有关事宜公告如下： 一、本期债券基本情况 者公开发行公司债券（第二期）（品种二）。 付将按照债券登记机构的有关规定统计债券持有人名单，本息支付方 式及其他具体安排按照 ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其準確性或完整性亦不發表任何聲 明，並明確表示概不就因本公告全部或任何部分內容而產生或因倚賴該等內容而引致的任何損失承擔任何責任。 （ 於 中 華 人 民 共 和 國 註 冊 成 立 的 股 份 有 限 公 司 ） （股份代號：6806） 海外監管公告 本公告乃由申萬宏源集團股份有限公司（「本公司」）根據香港聯合交易所有限公司證券上市規 則第13.10B條作出。 茲載列本公司於深圳證券交易所網站發佈之《申萬宏源集團股份有限公司2023年面向專業投資 者公開發行公司債券（第二期）（品種二）2025年付息公告》，僅供參閱。 承董事會命 申萬宏源集團股份有限公司 董事長 劉健 北京，2025年9月3日 於本公告日期，董事會成員包括執行董事劉健先生及黃昊先生；非執行董事朱志龍先生、張英女士、邵亞樓先生、 徐一心先生及嚴金國先生；獨立非執行董事楊小雯女士、武常岐先生、陳漢文先生及趙磊先生。 证券代码：000166 证券简称：申万宏源 公告编号：临 2025-72 债券代码：148449 债券简称：23 申宏 04 申万宏源集团股份有限公司 202 ...

Core Viewpoint - Lianhua Technology (002250) has experienced significant profit growth in the first half of 2025, driven by cost reduction, operational efficiency improvements, and favorable exchange rate gains [1] Group 1: Profit Growth Reasons - The company's profit in the first half of 2025 increased significantly compared to the same period last year due to continuous cost reduction and efficiency enhancement [1] - The utilization rate of the plant protection business improved, and the product structure was adjusted, leading to an increase in gross margin [1] - The pharmaceutical business saw notable growth due to concentrated shipments and substantial exchange rate gains [1] Group 2: Pharmaceutical Business Developments - The pharmaceutical business growth is attributed to a focus on major clients, with partnerships established with several leading global pharmaceutical companies [1] - The company is actively expanding its client base, particularly targeting strategic and high-viscosity clients [1] - Collaborations have been established with a number of high-quality domestic and international clients [1] Group 3: Plant Protection Business Factors - The company follows a customer-centric strategy, providing a stable supply chain, comprehensive product delivery capabilities, and high-quality services [1] - The UK subsidiary improved its capacity utilization and operational performance in the first half of the year [1] - The UK subsidiary also achieved significant exchange rate gains, enhancing overall performance [1] Group 4: New Energy Project Progress - The company has achieved stable supply and gradual production increases for electrolyte products [1] - New energy products, including main salt products and cathode materials, have achieved stable commercial delivery [1] - The company anticipates that revenue from the new energy business will exceed expectations in 2025 [1] Group 5: Solid-State Battery Strategy - The company is actively monitoring industry trends and developing products in response to customer needs [1] - There is a focus on optimizing services and technology to reduce costs and promote innovation [1] Group 6: Competitive Landscape in India - Indian companies have entered the CDMO field, primarily focusing on generic drug supply chains, with unclear competitiveness in patented drugs [1] - While India has advantages in compliance and labor costs, China possesses a more comprehensive supply chain and a mature waste treatment system [1] - The company believes that maintaining its competitive edge will allow it to sustain market share and profitability despite emerging competitors [1]

证券代码：000166 证券简称：申万宏源 公告编号：临 2025-72 债券代码：148449 债券简称：23 申宏 04 申万宏源集团股份有限公司 2023年面向专业投资者公开发行公司债券（第二期） （品种二）2025年付息公告 本公司及全体董事会成员保证公告内容的真实、准确和完整，没 有虚假记载、误导性陈述或者重大遗漏。 特别提示： 1、申万宏源集团股份有限公司 2023 年面向专业投资者公开发行 公司债券（第二期）（品种二）（债券简称：23 申宏 04，债券代码： 148449）将于 2025 年 9 月 5 日支付自 2024 年 9 月 5 日至 2025 年 9 月 4 日期间的利息 2.85 元（含税）/张。 2、本次付息的债权登记日为 2025 年 9 月 4 日，凡在 2025 年 9 月 4 日（含）前买入并持有本期债券的投资者享有本次派发的利息； 2025 年 9 月 4 日卖出本期债券的投资者不享有本次派发的利息。 由申万宏源集团股份有限公司（以下简称"本公司"）于 2023 年 9 月 5 日发行的申万宏源集团股份有限公司 2023 年面向专业投资 者公开发行公司债券（第二期）（品 ...